Aethlon Medical, Inc.
(NASDAQ : AEMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.03%485.951.0%$1015.47m
ABTAbbott Laboratories -0.48%111.090.8%$906.88m
DHRDanaher Corp. 0.64%258.720.7%$723.78m
MDTMedtronic Plc -1.17%123.740.6%$603.72m
ISRGIntuitive Surgical, Inc. -0.05%884.542.3%$471.64m
BDXBecton, Dickinson & Co. 0.47%241.391.0%$357.28m
DXCMDexCom, Inc. 0.86%416.017.8%$300.99m
ALGNAlign Technology, Inc. -0.75%608.746.3%$284.02m
SYKStryker Corp. -0.98%257.021.3%$276.77m
BSXBoston Scientific Corp. -0.38%43.191.0%$269.07m
EWEdwards Lifesciences Corp. 0.15%101.140.4%$236.68m
BAXBaxter International, Inc. -0.38%80.851.8%$220.46m
AAgilent Technologies, Inc. -0.76%145.811.6%$216.82m
ZBHZimmer Biomet Holdings, Inc. -0.92%158.911.7%$198.34m
IDXXIDEXX Laboratories, Inc. -0.10%603.623.8%$195.80m

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.